Journal of Enzyme Inhibition and Medicinal Chemistry (Dec 2023)

Different chemical proteomic approaches to identify the targets of lapatinib

  • Tatjana Kovačević,
  • Krunoslav Nujić,
  • Mario Cindrić,
  • Snježana Dragojević,
  • Adrijana Vinter,
  • Amela Hozić,
  • Milan Mesić

DOI
https://doi.org/10.1080/14756366.2023.2183809
Journal volume & issue
Vol. 38, no. 1

Abstract

Read online

The process of identifying the protein targets and off-targets of a biologically active compound is of great importance in modern drug discovery. Various chemical proteomics approaches have been established for this purpose. To compare the different approaches, and to understand which method would provide the best results, we have chosen the EGFR inhibitor lapatinib as an example molecule. Lapatinib derivatives were designed using linkers with motifs, including amino (amidation), alkyne (click chemistry) and the diazirine group (photo-affinity). These modified lapatinib analogues were validated for their ability to inhibit EGFR activity in vitro and were shown to pull down purified recombinant EGFR protein. In all of the approaches evaluated here, we identified EGFR as the main protein target from the lysate of immortalised cell line expressing EGFR, thus validating its potential use to identify unknown protein targets. Taken together, the results reported here give insight into the cellular activities of lapatinib.

Keywords